If the cancer comes back or gets worse, you may need to start treatment again. Physical Health The physical effects of hormone therapy for prostate cancer can impact your daily life. Cancer treatment affects people in different ways, so you may not have every side effect. You may notice: Ho...
ProstateDepressionHormoneTo investigate the relationship between hormone therapy (HT) and incidence of anxiety and depression among prostate cancer patients (PCa).526 PCa patients completed a survey about their cancer status, treatment received, anxiety, and depression status. Total scores on anxiety and...
Hormone therapy for prostate cancer can cause bone thinning osteoporosis, which can lead to broken bones. However, treatment with bisphosphonates -- likeAredia,Fosamax, andZometa-- may help prevent this condition from developing, says Holden. ...
Future Prospects for Luteinizing Hormone-Releasing Hormone Analogues in Prostate Cancer Treatment Luteinizing hormone-releasing hormone (LHRH) analogues play a pivotal role in hormonal therapy regimens for the treatment of prostate cancer. Hormonal ther... H Akaza - 《Pharmacology》 被引量: 40发表: ...
Hormone Therapies for Prostate Cancer Treatment Male hormones (called androgens) cause prostate cancer cells to grow. Androgens support a healthy prostate gland; however, they can also promote the growth of cancerous prostate cells. When using hormone therapy for prostate cancer, the treatment can bl...
Fargo agreed. "I don't think any doctors are going to make different decisions based on this single study," he said. "If your doctor has put you on this medication for yourprostate cancertreatment, you should continue it. Consult with your physician, but don't stop taking your medication...
Abstract. For metastatic prostate cancer, androgen deprivation therapy (ADT) is the key strategy to control the disease. However, after 18–24 months of tre
(AP) -- A new study links hormone therapy for prostate cancer with a higher risk of death in older men who've had serious heart problems. Ad Hormone therapy suppresses the amount of testosterone produced, in turn causing prostate tumors to shrink or grow more slowly. The treatment, involving...
Hormone-targeted treatment has previously been linked to a higher risk of diabetes and heart disease. Azoulay and his colleagues took UK data on 10,250 men who were diagnosed with prostate cancer between 1997 and 2008. The men were followed for an average of just over four years after their...
For those men not suitable for local treatment, androgen deprivation therapy (ADT) remains an option. METHODS: Literature review of the evidence relating to the management of hormone therapy for radiorecurrent prostate cancer. RESULTS: Results from retrospective studies have shown that not all men ...